Institutional investors purchased a net $465.9 thousand shares of ATHX during the quarter ended September 2017 and now own 19.77% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WEST OAK CAPITAL LLC Bought 300.00 shares of Athersys Inc
EDGE WEALTH MANAGEMENT LLC Sold 7.5 Thousand shares of Athersys Inc